Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.78B |
| 2 |
Microsoft
MSFT
|
+$2.22B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.67B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.65B |
| 5 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.19B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.45B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$533M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$410M |
| 4 |
Stellantis
STLA
|
+$312M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.28% |
| 2 | Healthcare | 11.27% |
| 3 | Financials | 10.52% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AYX
1026
PUT
DELISTED
Alteryx Inc
AYX
| $9.08M | 0.01% |
200,000
+100,000
| +100% | +$4.38M |
|
1027
Burford Capital
BUR
$971M
| $9.07M | 0.01% |
744,559
+160,839
| +28% | +$2.08M |
|
1028
PUT
Pfizer
PFE
$153B
| $9.07M | 0.01% |
247,200
-588,600
| -70% | -$22.9M |
|
1029
C3.ai
AI
$1.59B
| $9.04M | 0.01% |
248,277
+192,054
| +342% | +$5.41M |
|
1030
ArcBest
ARCB
$3.08B
| $9.03M | 0.01% |
91,416
+75,126
| +461% | +$6.71M |
|
|
LAZR
1031
DELISTED
Luminar Technologies
LAZR
| $9.01M | 0.01% |
87,287
-56,132
| -39% | -$5.3M |
|
1032
Commercial Metals
CMC
$8.31B
| $8.95M | 0.01% |
169,992
-28,937
| -15% | -$1.35M |
|
1033
Tradeweb Markets
TW
$21.6B
| $8.95M | 0.01% |
130,714
+24,096
| +23% | +$1.71M |
|
1034
Idacorp
IDA
$8.2B
| $8.92M | 0.01% |
86,896
+41,480
| +91% | +$4.46M |
|
|
CPRX
1035
DELISTED
Catalyst Pharmaceutical
CPRX
| $8.91M | 0.01% |
662,685
+468,846
| +242% | +$6.75M |
|
|
LSXMK
1036
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $8.89M | 0.01% |
350,585
+175,759
| +101% | +$3.93M |
|
1037
Vanguard Morningstar Total Stock Market ETF
VTI
$684B
| $8.89M | 0.01% |
40,338
+2,340
| +6% | +$488K |
|
1038
AutoNation
AN
$6.92B
| $8.88M | 0.01% |
53,939
-8,155
| -13% | -$1.13M |
|
1039
Kymera Therapeutics
KYMR
$8.94B
| $8.85M | 0.01% |
384,983
+25,055
| +7% | +$718K |
|
1040
Super Micro Computer
SMCI
$20.1B
| $8.84M | 0.01% |
354,560
-545,630
| -61% | -$9.14M |
|
1041
Omnicell
OMCL
$1.68B
| $8.83M | 0.01% |
119,869
+22,252
| +23% | +$1.5M |
|
1042
PUT
T-Mobile US
TMUS
$190B
| $8.81M | 0.01% |
63,400
-114,200
| -64% | -$16M |
|
1043
Penumbra
PEN
$12.8B
| $8.8M | 0.01% |
25,572
+17,285
| +209% | +$5.31M |
|
1044
Murphy Oil
MUR
$4.78B
| $8.8M | 0.01% |
229,707
+94,371
| +70% | +$3.48M |
|
1045
Commerce Bancshares
CBSH
$8.5B
| $8.72M | 0.01% |
207,200
+144,102
| +228% | +$6.39M |
|
1046
iShares Silver Trust
SLV
$30.7B
| $8.7M | 0.01% |
416,243
-239,564
| -37% | -$5.33M |
|
|
DOC
1047
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $8.68M | 0.01% |
620,620
+989
| +0.2% | +$14.1K |
|
|
KCGI
1048
DELISTED
Kensington Capital Acquisition Corp. V
KCGI
| $8.55M | 0.01% |
809,703
| – | – |
|
1049
Moelis & Co
MC
$4.94B
| $8.54M | 0.01% |
188,295
+140,265
| +292% | +$5.6M |
|
1050
Duolingo
DUOL
$6.12B
| $8.5M | 0.01% |
59,444
+28,283
| +91% | +$4.05M |
|
Similar funds
Barclays's Q2 2023 Portfolio in Review
As of Q2 2023, Barclays held 5,371 positions worth $158B, down 28% from $218B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays withdrew a net $70.1B in Q2 2023, closing 872 positions and reducing 1,669 holdings. Its most notable exit was DCP Midstream, LP, an estimated $47.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR Nuveen ICE Municipal Bond ETF worth $36.9M.
- Barclays's largest Q2 2023 buy was State Street SPDR Nuveen ICE Municipal Bond ETF: 799,988 shares worth $36.9M.
- Barclays added most to Apple in Q2 2023, an estimated $2.78B increase.
- Barclays's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.45B.
- Barclays fully exited DCP Midstream, LP in Q2 2023, selling an estimated $47.3M.
- Barclays's ten largest holdings make up 24% of its $158B portfolio in Q2 2023.
- Barclays opened 314 new positions and closed 872 in Q2 2023.
- Barclays's portfolio value fell 28% quarter-over-quarter to $158B.
Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.